Indexed In
- Open J Gate
- Cosmos IF
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Cardiovascular Pharmacology: Open Access have been cited by esteemed scholars and scientists all around the world. Cardiovascular Pharmacology: Open Access has got h-index 6, which means every article in Cardiovascular Pharmacology: Open Access has got 6 average citations.
Following are the list of articles that have cited the articles published in Cardiovascular Pharmacology: Open Access.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Total published articles |
60 | 43 | 8 | 10 | 21 |
Conference proceedings |
9 | 0 | 0 | 29 | 42 |
Citations received as per Google Scholar, other indexing platforms and portals |
17 | 22 | 27 | 29 | 27 |
| Journal total citations count | 218 |
| Journal impact factor | 0.37 |
| Journal 5 years impact factor | 0.87 |
| Journal cite score | 1.44 |
| Journal h-index | 6 |
Important citations
Yaniv Y, Ahmet I, Liu J, Lyashkov AE, Guiriba TR, et al (2014) Synchronization of sinoatrial node pacemaker cell clocks and its autonomic modulation impart complexity to heart beating intervals. Heart Rhythm 11: 1210-1219.
Preeti J, Alexandre M, Pupalan I, C Merlin T, Claudio R (2016) Chronic Heart Failure and Comorbid Renal Dysfunction-A Focus on Type 2 Cardiorenal Syndrome. Current cardiology reviews 12: 186-194.
Iyngkaran P, Kangaharan N, Zimmet H, Arstall M, Minson R, et al. (2016) J. Heart Failure in Minority Populations-Impediments to Optimal Treatment in Australian Aborigines. Current cardiology reviews 12: 166-179.
Kolathuru SS, Yeung PK (2014) Natural Health Products as Modulators of Adenosine and ATP Metabolism for Cardiovascular Protection. Natural Products Chemistry & Research.
KF Yeung P, Tinkel J, Seeto D (2015) A Pilot Study to Assess Adenosine 5’-triphosphate Metabolism in Red Blood Cells as a Drug Target for Potential Cardiovascular Protection. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders) 15: 224-232.
Burnstock G, Pelleg A (2015) Cardiac purinergic signalling in health and disease. Purinergic signalling 11: 1-46.
Effat M, Alsidawi S (2013) The Role of Bivalirudin in Percutaneous Coronary Intervention. Cardiovascular Pharmacology: Open Access.
Yang Q (2014) Role of MicroRNAs in Hypoxia-Induced Pulmonary Hypertension. Cardiovascular Pharmacology: Open Access.
Sun M, Yang Q (2014) Neonatal hyperoxia and pulmonary hypertension. Pediatr Neonatal Nurs Open J 1: 1-5.
Ruberg FL, Leopold JA, Loscalzo J (2002) Atherothrombosis: plaque instability and thrombogenesis. Progress in cardiovascular diseases 44: 381-394.
Covelo SL, Saura M, Morán P (2015) Does DNA methylation regulate metamorphosis? The case of the sea lamprey (Petromyzon marinus) as an example. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 185: 42-46.
Kloner RA (2015) Testosterone and cardiovascular health: safety of treatment of hypogonadism. Sexual Medicine Reviews 3: 56-62.
Sun M, Yang Q (2014) Neonatal hyperoxia and pulmonary hypertension. Pediatr Neonatal Nurs Open J 1: 1-5.
Yang Q, Sun M, Ramchandran R, Raj JU (2015) IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: role of epigenetic regulation. Vascul Pharmacol 73: 20-31.
Aksoy UD, Akdemir R (2016) Testosteronun kardiyovasküler hastalıklar ile ilişkisi. Androloji Bülteni 18: 160-162.
Pongkan W, Chattipakorn SC, Chattipakorn N (2016) Roles of Testosterone Replacement in Cardiac Ischemia–Reperfusion Injury.J Cardiovasc Pharmacol Ther 21: 27-43.
Kloner RA (2015) Testosterone and cardiovascular health: safety of treatment of hypogonadism. Sex Med Rev 3: 56-62.
Kloner RA, Carson C, Dobs A, Kopecky S, Mohler ER (2016) Testosterone and cardiovascular disease. J Am Coll Cardiol 67: 545-557.
Yang Q, Diamond MP, Al-Hendy A (2016) The emerging role of extracellular vesicle-derived miRNAs: Implication in cancer progression and stem cell related diseases. J Clin Epigenet 2: 13.
Kumar A (2016) Innovative Approaches in the field of Cardiology. Research & Reviews in BioSciences 11: 109.